We found that CD31 high expressing tumors had higher fractions of anti-cancer T cells, including CD8+ T cells (p = 0.027), activated memory CD4+ T cells (p = 0.038) and Gamma delta T cells (p < 0.001) (Fig. 7A). This evidence concerns the gene CD4 and cancer.